LexaGene
Top Five Articles on 360Dx Last Week: Lucira Health Bankruptcy; BioMérieux New MDx System; and More
Last week, readers were most interested in Lucira's plans for bankruptcy, filed days before the firm received FDA EUA for a new molecular COVID-19/flu test.
LexaGene Files for Chapter 7 Bankruptcy
The company has ceased operations and laid off staff, while a bankruptcy trustee will liquidate its assets and distribute any proceeds.
In Brief This Week: MDxHealth, PerkinElmer, OpGen, Intelligent Bio Solutions, Novacyt, More
News items for the week of Oct. 24, 2022.
LexaGene Reports $58K in Fiscal Q4 Revenues, Spurred by MiQLab Launch
The Beverly, Massachusetts-based firm noted that all revenue from its MiQLab was generated from US customers.
In Brief This Week: Abbott Laboratories, LexaGene, Caris Life Sciences, SQI Diagnostics, and More
News items for the in vitro diagnostics industry for the week of March 1, 2021.
Oct 29, 2019